In this study we have investigated the anticancer effects and mechanisms of action of α-santalol on human breast cancer cells by using MCF-7 cells (p53 wild type) as a model for estrogen receptor (ER)-positive and MDA-MB-231 cells (p53 mutant) as a model for ER-negative breast cancer. Here, TP53 is linked to breast carcinoma.